Literature DB >> 15592089

DNA hypomethylation on pericentromeric satellite regions significantly correlates with loss of heterozygosity on chromosome 9 in urothelial carcinomas.

Tohru Nakagawa1, Yae Kanai, Saori Ushijima, Tadaichi Kitamura, Tadao Kakizoe, Setsuo Hirohashi.   

Abstract

PURPOSE: DNA methylation has important roles in genomic stability. Accordingly DNA hypomethylation on pericentromeric satellite regions may induce chromosomal instability through heterochromatin decondensation and chromosomal recombination enhancement. We elucidated the significance of aberrant DNA methylation on pericentromeric satellite regions during urothelial carcinogenesis.
MATERIALS AND METHODS: We examined DNA methylation status on satellites 2 and 3 by Southern blotting and determined the allelic status of chromosome 9 using 6 microsatellite markers (D9S775, D9S925, D9S304, D9S303, D9S283 and D9S747) in 27 transitional cell carcinomas of the bladder, ureter or renal pelvis and corresponding noncancerous tissues.
RESULTS: DNA hypomethylation on satellites 2 and 3 was detected in 2 (7%) and no (0%) noncancerous tissues, and in 11 (41%) and 12 (44%) urothelial carcinomas, respectively. DNA hypomethylation in urothelial carcinomas significantly correlated with histological grade (p = 0.0012 and 0.0043), invasion depth (p = 0.0055 and 0.0228) and morphological structure (papillary vs nodular, p = 0.0161 and 0.0297) for satellites 2 and 3, respectively. Loss of heterozygosity on at least 1 locus of chromosome 9 was detected in 14 urothelial carcinomas (52%). DNA hypomethylation on satellites 2 (p = 0.0098) and 3 (p = 0.0034) significantly correlated with loss of heterozygosity on chromosome 9.
CONCLUSIONS: DNA hypomethylation on pericentromeric satellite regions may participate in the development and progression of urothelial carcinomas by inducing loss of heterozygosity on chromosome 9.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15592089     DOI: 10.1097/01.ju.0000141577.98902.49

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  21 in total

Review 1.  Epigenetics and human disease: translating basic biology into clinical applications.

Authors:  David Rodenhiser; Mellissa Mann
Journal:  CMAJ       Date:  2006-01-31       Impact factor: 8.262

Review 2.  DNA hypomethylation in the origin and pathogenesis of human diseases.

Authors:  Igor P Pogribny; Frederick A Beland
Journal:  Cell Mol Life Sci       Date:  2009-03-27       Impact factor: 9.261

3.  Towards understanding the epigenetics of transcription by chromatin structure and the nuclear matrix.

Authors:  Rui Pires Martins; Stephen A Krawetz
Journal:  Gene Ther Mol Biol       Date:  2005

Review 4.  Epigenetic markers in melanoma.

Authors:  Weimin Guo; Ting Xu; Jonathan J Lee; George F Murphy; Christine G Lian
Journal:  Melanoma Manag       Date:  2015-11-24

5.  Genome-wide CpG island methylation and intergenic demethylation propensities vary among different tumor sites.

Authors:  Seung-Tae Lee; Joseph L Wiemels
Journal:  Nucleic Acids Res       Date:  2015-10-12       Impact factor: 16.971

6.  Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study.

Authors:  Lee E Moore; Ruth M Pfeiffer; Cristina Poscablo; Francisco X Real; Manolis Kogevinas; Debra Silverman; Reina García-Closas; Stephen Chanock; Adonina Tardón; Consol Serra; Alfredo Carrato; Mustafa Dosemeci; Montserrat García-Closas; Manel Esteller; Mario Fraga; Nathaniel Rothman; Núria Malats
Journal:  Lancet Oncol       Date:  2008-03-12       Impact factor: 41.316

7.  Pericentromeric Satellite III transcripts induce etoposide resistance.

Authors:  Julian Kanne; Michelle Hussong; Jörg Isensee; Álvaro Muñoz-López; Jan Wolffgramm; Felix Heß; Christina Grimm; Sergey Bessonov; Lydia Meder; Jie Wang; H Christian Reinhardt; Margarete Odenthal; Tim Hucho; Reinhard Büttner; Daniel Summerer; Michal R Schweiger
Journal:  Cell Death Dis       Date:  2021-05-24       Impact factor: 8.469

8.  Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas.

Authors:  Eri Arai; Suenori Chiku; Taisuke Mori; Masahiro Gotoh; Tohru Nakagawa; Hiroyuki Fujimoto; Yae Kanai
Journal:  Carcinogenesis       Date:  2012-05-18       Impact factor: 4.944

Review 9.  Epigenomic and Metabolomic Integration Reveals Dynamic Metabolic Regulation in Bladder Cancer.

Authors:  Alba Loras; Cristina Segovia; José Luis Ruiz-Cerdá
Journal:  Cancers (Basel)       Date:  2021-05-31       Impact factor: 6.639

10.  Cytogenetic effect of 5-azacytidine in patients with hematological malignancies.

Authors:  Jessica Romy Tsuda; Rosimeire Segato; Waldênia Barbosa; Marília de Arruda Cardoso Smith; Spencer Luiz Marques Payão
Journal:  Rev Bras Hematol Hemoter       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.